Zoetis Inc (NYSE:ZTS)

165.13
Delayed Data
As of Jan 27
 -3.11 / -1.85%
Today’s Change
124.15
Today|||52-Week Range
205.31
+12.68%
Year-to-Date
4 Top Stocks With High Dividend Growth to Buy in 2023 and Hold Forever
10:15am / MotleyFool.com - Paid Partner Content
If You Invested $5,000 in Zoetis in 2013, This Is How Much You Would Have Today
Jan 18 / MotleyFool.com - Paid Partner Content
Zoetis (ZTS) Stock Sinks As Market Gains: What You Should Know
Jan 27 / Zacks.com - Paid Partner Content
3 Reasons to Buy Zoetis, and 1 Reason to Sell
Jan 17 / MotleyFool.com - Paid Partner Content
UTHR vs. ZTS: Which Stock Is the Better Value Option?
Jan 27 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close168.24
Today’s open167.47
Day’s range164.48 - 167.54
Volume1,831,718
Average volume (3 months)2,286,642
Market cap$76.3B
Data as of 4:00pm ET, 01/27/2023

Growth & Valuation

Earnings growth (last year)+24.66%
Earnings growth (this year)+4.03%
Earnings growth (next 5 years)+10.07%
Revenue growth (last year)+16.49%
P/E ratio37.7
Price/Sales14.96
Price/Book17.04

Competitors

----
REGNRegeneron Pharmaceut...0.000.00%
GLAXFGlaxoSmithKline+0.47+2.72%
GSKGlaxoSmithKline+0.01+0.03%
Data as of 4:00pm ET, 01/27/2023

Financials

Next reporting dateFebruary 14, 2023
EPS forecast (this quarter)$1.15
Annual revenue (last year)$7.8B
Annual profit (last year)$2.0B
Net profit margin26.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Parsippany, New Jersey

Forecasts